Safety and Efficacy Study of Eculizumab in Shiga-Toxin Producing Escherichia Coli Hemolytic-Uremic Syndrome (STEC-HUS)
Clinical trial NCT01410916 · COMPLETED
Trial details
- NCT number
- NCT01410916
- Sponsor
- Alexion Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2011-07-01
- Primary completion
- 2012-01-01
- Enrollment
- 198
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.